Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with glaucoma
- People aged 18 years or older
- People whose glaucoma is not adequately controlled with current eye medications
- People for whom a doctor has decided that a specific laser treatment (called MP-CPC Laser) is the appropriate course of action
Who may not be able to join:
- People under the age of 18
- People who are unable or unwilling to give their formal written consent to take part in the study
- People who may not be available to attend follow-up appointments during the study
- People who have significant thinning of the white outer wall of the eye (confirm with trial site)
- People who have had an eye infection, eye inflammation, or eye surgery in the eye being studied within the 2 months before enrolling
- People with albinism who have no pigmentation (colouring) in the iris of the eye
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Assiya Shaikenova, MD, Kazakh Eye Research Institute
Phone: +77055689966
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Association Between Changes in Tear Fluid Interleukin Levels and Intraocular Pressure Reduction
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.